FY2025-2034 DTRA Chemical and Biological Technologies Fundamental Research Broad Agency Announcement
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Threat Reduction Agency (DTRA) has issued a Broad Agency Announcement (BAA) for Fundamental Research in Chemical and Biological Technologies for fiscal years 2025-2034. This BAA seeks innovative scientific and technological advancements to Counter Weapons of Mass Destruction (C-WMD) threats. Awards will primarily be grants, but cooperative agreements or other transactions may also be used; no contracts will be awarded. The BAA is open continuously until September 30, 2034, with specific topic deadlines. Pre-application white papers for Topics B1-B6 are due March 2, 2026.
Scope of Work
DTRA aims to identify, adopt, and adapt emerging and revolutionary sciences with high payoff potential for C-WMD. This includes basic and applied research (TRLs 1-4) that contributes to the body of knowledge, advances technology, or offers new concepts for C-WMD threat reduction. A portion of the effort is dedicated to STEM education programs with a C-WMD focus, such as postdoctoral fellowships and curriculum development. Research areas include improved detection, diagnostics, medical/material countermeasures, personal protection, modeling, decontamination, and non-kinetic elimination strategies for chemical and biological WMD.
Contract & Timeline
- Type: Broad Agency Announcement (BAA) for grants, cooperative agreements, or other transactions.
- Duration: Open continuously from October 1, 2024, through September 30, 2034.
- Anticipated Awards: Up to five years, with annual values ranging from $25,000 to $1,000,000. Approximately 30 individual awards are anticipated annually.
- Set-Aside: None specified.
- Pre-application White Paper Deadline (Topics B1-B6): March 2, 2026, at 11:59 PM EST.
- Published Date (Amendment 4): February 4, 2026.
Eligibility & Submission
- Eligible Entities: Accredited degree-granting colleges, universities, academic institutions, industrial/commercial entities (including small businesses), not-for-profit entities, and foreign government laboratories. Federal organizations, laboratories, and U.S. Government agencies are excluded as prime awardees but may collaborate.
- Submission Process: Submissions occur in two phases. Phase I requires pre-application white papers, followed by Phase II for invited proposal applications.
- Pre-coordination: Generally required for abstract submissions, but waived for Topics B1-B6 (and A1-A7). If a white paper is received without prior coordination (where required), DTRA may not review it.
- Platform: Submissions must be made through www.grants.gov.
- Required Registrations: Active System for Award Management (SAM) registration and a Grants.gov account are mandatory.
Evaluation Criteria
Evaluation for invited proposals will consider:
- Scientific and Technical Merit
- Value to Mission Goals
- Capability of Personnel and Facilities
- Cost Realism
Additional Notes
Research involving human subjects or animals requires specific approvals. Dual-use research of concern (DURC) will not be funded. This BAA is for fundamental research, defined within Technology Readiness Levels (TRLs) 1-4.